⌘K
Loading ticker…
As of 2026-08-25, BioAge Labs, Inc. Common Stock (BIOA) has a 3-month relative strength percentile of 10 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 8.8%, relative volume 0.36×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
BIOA is in a stage 3 topping pattern, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -44.8% / -40.0%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
BIOA is held by 19 ETFs as of May 2026. Top owner: VTWO at 0.02% weight, $3M notional. Top 3 carry $7M.
Held by 40 ETFs · $66M across latest filings · largest weight 1.20% (XPH).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.02% | $3M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $2M | — |
| VFMO | 0.12% | $2M | −0.03 pp |
| DWAS | 0.38% | $2M | −0.24 pp |
| AVSC | 0.03% | $753K | +0.01 pp |
| VTWV | 0.03% | $413K | — |
| ONEQ | 0.00% | $357K | new |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $279K | — |
| GSSC | 0.02% | $187K | new |
| VTHRVanguard Russell 3000 ETF | 0.00% | $48K | — |
Showing 10 of 19 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BIOA Jan avg: 11.41% median: 11.41% win: 50% σ: 45.44% n: 2 2024-09-27 → 2026-07-31 | BIOA Feb avg: 9.07% median: 9.07% win: 100% σ: 11.60% n: 2 2024-09-27 → 2026-07-31 | BIOA Mar avg: -20.13% median: -20.13% win: 0% σ: 1.89% n: 2 2024-09-27 → 2026-07-31 | BIOA Apr avg: 4.02% median: 4.02% win: 50% σ: 10.86% n: 2 2024-09-27 → 2026-07-31 | BIOA May avg: -1.55% median: -1.55% win: 50% σ: 5.89% n: 2 2024-09-27 → 2026-07-31 | BIOA Jun avg: 23.03% median: 23.03% win: 100% σ: 26.49% n: 2 2024-09-27 → 2026-07-31 | BIOA Jul avg: -28.29% median: -28.29% win: 50% σ: 49.25% n: 2 2024-09-27 → 2026-07-31 | BIOA Aug avg: 12.04% median: 12.04% win: 100% σ: 0.00% n: 1 2024-09-27 → 2026-07-31 (current) | BIOA Sep avg: 16.43% median: 16.43% win: 100% σ: 4.01% n: 2 2024-09-27 → 2026-07-31 | BIOA Oct avg: 21.10% median: 21.10% win: 100% σ: 10.80% n: 2 2024-09-27 → 2026-07-31 | BIOA Nov avg: 2.51% median: 2.51% win: 50% σ: 32.32% n: 2 2024-09-27 → 2026-07-31 | BIOA Dec avg: -14.90% median: -14.90% win: 50% σ: 76.80% n: 2 2024-09-27 → 2026-07-31 |